Merck, Bristol-Myers agree to settle Keytruda patent suit

(Reuters) – Merck & Co said it agreed to enter into a settlement and license agreement with Bristol-Myers Squibb Co and Ono Pharmaceutical Co Ltd to resolve all global patent-infringement litigation related to its cancer drug, Keytruda.

Advertisements
Merck, Bristol-Myers agree to settle Keytruda patent suit